JoVE Logo

Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Established immunochemical methods to measure peptide transmitters in vivo rely on microdialysis or bulk fluid draw to obtain the sample for offline analysis. However, these suffer from spatiotemporal limitations. The present protocol describes the fabrication and application of a capacitive immunoprobe biosensor that overcomes the limitations of the existing techniques.

Abstract

The ability to measure biomarkers in vivo relevant to the assessment of disease progression is of great interest to the scientific and medical communities. The resolution of results obtained from current methods of measuring certain biomarkers can take several days or weeks to obtain, as they can be limited in resolution both spatially and temporally (e.g., fluid compartment microdialysis of interstitial fluid analyzed by enzyme-linked immunosorbent assay [ELISA], high-performance liquid chromatography [HPLC], or mass spectrometry); thus, their guidance of timely diagnosis and treatment is disrupted. In the present study, a unique technique for detecting and measuring peptide transmitters in vivo through the use of a capacitive immunoprobe biosensor (CI probe) is reported. The fabrication protocol and in vitro characterization of these probes are described. Measurements of sympathetic stimulation-evoked neuropeptide Y (NPY) release in vivo are provided. NPY release is correlated to the sympathetic release of norepinephrine for reference. The data demonstrate an approach for the fast and localized measurement of neuropeptides in vivo. Future applications include intraoperative real-time assessment of disease progression and minimally invasive catheter-based deployment of these probes.

Introduction

Several chemical methods for detecting and quantifying biomarkers are routinely utilized in both protein chemistry and clinical diagnostics, particularly in cancer diagnoses and the assessment of cardiovascular disease progression. Currently, methods such as high-performance liquid chromatography (HPLC), enzyme-linked immunosorbent assay (ELISA), and mass spectrometry rely on sample collection from the vascular compartment1,2,3 by bulk fluid draw or the interstitial compartment by microdialysis. Microdialysis employs a semipermeable membrane tube of known length that is placed in a region of interest. Collection fluid is perfused through the tube over several minutes4 to collect the sample for analysis5, thus limiting temporal resolution. In this manner, samples collected only provide an averaged value over time of the local microenvironment and are limited by the perfusion rate and collection of sufficient sample volume. Moreover, these methods require the pooling of experimental data and signal averaging; therefore, they may fail to account for variability between subjects. Importantly, the time between sample collection and subsequent offline analysis precludes immediate clinical intervention and therapeutics.

In the present protocol, the use of a capacitive immunoprobe biosensor (CI probe) for the time-resolved electrical detection of specific bioactive peptides is outlined. Neuropeptide Y (NPY), released from post-ganglionic sympathetic neurons that innervate the vasculature, endocardium, cardiomyocytes, and intracardiac ganglia, is a major neuromodulatory peptide transmitter in the cardiovascular system6,7,8,9. The method presented here is designed to measure NPY, and the experimental feasibility is demonstrated in a porcine heart model. However, this approach applies to any bioactive peptide for which a selective antibody is available10. This method relies on the capacitive junction between a platinum wire probe and the conductive fluid at the functionalized tip11,12. In this application, the interaction was mediated through an antibody against the target neuropeptide (NPY), which was bound to the electrode tip, interfacing the conductive fluid environment. This functionalization was achieved through electrodeposition of reactive polydopamine onto the tip of the platinum wire probe10,13.

When the antibody-functionalized probe is placed in a region of interest in vivo, evoked endogenous NPY release leads to binding to the trapping antibodies on the probe tip, and the conductive fluid at the electrode surface is displaced by the NPY protein. Local alteration in the electrical environment results in the displacement of high-mobility, high-dielectric fluid with an immobile, statically charged molecule. This alters the electrode-fluid interface and, thus, its capacitance, which is measured as a change in charge current in response to a step-function command potential. A negative "reset" potential is employed immediately following each individual measurement cycle to repel bound NPY from the antibody through electrostatic interaction, thus clearing the antibody binding sites for subsequent rounds of measurement10. This effectively allows for the measurement of NPY in a time-resolved manner. The unique CI technique overcomes the limitations of the microdialysis-based immunochemical methods outlined above to measure dynamic biomarker levels from a single experiment without data pooling or signal averaging over several experiments9, providing data in nearly real time. Moreover, the ability to adapt this method to any biomarker of interest for which there exists an appropriate antibody on a time-resolved and localized scale provides a major technical advance in immunochemical measurement for the evaluation of disease progression and the guidance of therapeutic interventions.

The software for data acquisition and analysis was custom-written in IGOR Pro (a fully interactive software environment). An analog to digital converter (A/D) system issued a command voltage under computer control and acquired data from a custom amplifier. The amplifier possessed certain unique features. These included a feedback resistor (switchable) for each of the four acquisition channels, allowing for choosing 1 MOhm or 10 MOhm feedback voltage clamp circuits to integrate the variability of the electrode. A stage unit with a single head and mutual ground/reference circuit for all the four acquisition channels was also built to place the device close by the chest in a single physical module. A 1 MOhm feedback resistor setting was used to collect all the reported data.

The filter and gain settings were telegraphed from the amplifier and recorded within the data file. Data were filtered at 1 kHz via a 2-pole analog Bessel filter digitized at 10 kHz. The difference in potential between the probe and surrounding conductive solution creates a Helmholtz capacitive layer at the probe tip. Ligand binding to the antibody at the probe tip results in an altered local charge and, thus, a change in the Helmholtz capacitance. This change in the capacitive component of the circuit results in a shift in the magnitude of injected charge required to bring the probe to the potential in the step-function voltage protocol. Thus, the binding of a specific ligand to the functionalized probe results in an alteration in the electrode capacitance measurement as a change in peak capacitive current.

Protocol

All animal experiments were approved by the University of California, Los Angeles Animal Research Committee and performed following the guidelines set forth by the National Institutes of Health Guide for the Care and Use of Laboratory Animals (8th edition, 2011). Adult male Yorkshire pigs of approximately 75 kg were used for in vivo studies10.

1. Capacitive immunoprobe fabrication and functionalization

  1. Cut a 25 cm length of perfluoroalkoxy (PFA)-coated platinum wire (see Table of Materials) and strip approximately 5 mm of PFA coating from one end using a scalpel, being careful not to cut into the platinum wire.
  2. Insert the stripped end of the platinum wire into a gold-plated 1 mm male connector pin and crimp the connector pin teeth around the stripped end of the platinum wire using needle-nose pliers (see Table of Materials).
  3. Solder the platinum wire to the gold-plated connector pin. Be careful not to use an excessive amount of solder.
  4. Prepare dopamine solution by dissolving 50 mg of dopamine HCl in 50 mL of 10 mM phosphate-buffered saline (PBS, pH 6.0) by stirring.
  5. Once the dopamine is completely dissolved, place the tip of the platinum wire in the vessel containing the freshly made dopamine-supplemented PBS. Plug a gold connector pin into a channel of the headstage (see Table of Materials).
  6. Connect the AgCl disc electrode (ground electrode, see Table of Materials) to the ground channel in the headstage. Place the AgCl disc in the vessel containing dopamine-supplemented PBS and platinum wire; be careful only to submerge the disc electrode and not any length of the wire or solder. Connect a wire shunt into the reference channels of the headstage prior to proceeding.
  7. Open the interactive data acquisition software (see Table of Materials). Prepare a sawtooth electrodeposition command potential protocol with the following parameters: start potential = −0.6 V; end potential = +0.65 V; scan rate = 0.04 V∙s-1; duration of deposition = 420 s. Begin the polydopamine deposition protocol, ensuring that all the wires are connected properly.
  8. After completing the polydopamine deposition, remove the AgCl ground pellet and the tip of the platinum wire from the vessel, being careful not to disturb the tip of the platinum wire electrode. Place the tip of the wire into a microtube containing PBS (pH 7.4) for 2-5 min as the antibody solution is prepared; ensure the wire tip does not contact the sides or bottom of the microtube.
    NOTE: Antibody solution can be made during polydopamine deposition; however, the transfer of the platinum wire from the dopamine-containing vessel to the microtube of PBS following polydopamine deposition should not be skipped.
  9. Prepare the antibody solution. Combine the antibody of interest with PBS (pH 7.4) in a 1:20 ratio in a vessel of an appropriate size (e.g., a microtube).
    NOTE: The anti-NPY monoclonal antibody (see Table of Materials) used here was aliquoted at 1 mg/mL; an example antibody preparation here would be 4 µL of antibody to 76 µL of PBS.
  10. Soak the polydopamine-deposited tip of the platinum electrode in antibody solution for a minimum of 2 h at room temperature, again ensuring the platinum wire tip is suspended in solution and not resting on the interior surface of the microtube.
    NOTE: Recent implementation of this technique has favored using the platinum wire electrode immediately following this step instead of wet or dry storage for later use.
  11. After soaking in the antibody solution, briefly rinse the newly-functionalized capacitive immunoprobe (CI probe) tip in PBS (pH 7.4). The probe is now ready for use.

2. Experimental setup for in vitro detection and measurement of peptide

  1. Place the functional tip of the CI probe into the flow chamber, taking care not to disturb the tip of the electrode in any way, as doing so may damage the sensory tip of the probe.
    NOTE: The flow chamber was created by pouring silicone elastomer (see Table of Materials) into a 35 mm culture dish with an elongated ovoid space-filler in the center of the dish. After hardening, the ovoid shape is removed from the elastomer. The chamber is then superfused with Tris-buffered saline (TBS) and allowed a flow rate of 3 mL/min. Ensure the inflow and outflow maintain the fluid level in the chamber such that no tidal action of the superfusate is observed. The flow must remain in place for as long as the CI probe is in use.
  2. Prior to the first experimental test, perform a TBS standard run to condition the CI probe. Set up the following command voltage protocol: positive step potential = +100 mV; negative step potential = −5 mV; step duration = 20 ms; duration of acquisition = 600 s.
    NOTE: It is important to allow for the equilibration of the probe during the initial phase of cycling command potential prior to data acquisition.
  3. Create a solution of the peptide of interest using the same TBS to maintain the superfusate's composition. Set up a manifold system where the superfusate can be switched between TBS and peptide-supplemented TBS without introducing bubbles into the tubing system or flow chamber.
    NOTE: Synthetic porcine NPY peptide (see Table of Materials) was used in the present study.
  4. Set up the peptide-sensing data acquisition protocol using TBS standard parameters (see step 2.2.).
    ​NOTE: In this implementation, the duration of each experimental test was 360 s (120 s TBS, 120 s peptide-supplemented TBS, 120 s TBS).

3. Adaptation of the CI probe for in vivo use

  1. Prior to polydopamine deposition (step 1.7.), thread the exposed tip of the platinum wire electrode through a 22 G hypodermic needle, leaving approximately 2 mm beyond the tip of the needle. Using forceps, gently bend back the tip of the platinum wire electrode, creating a "barb" that hangs from the end of the hypodermic needle.
    1. Gently withdraw the needle from the barbed tip, leaving enough wire to place in the vessel without the needle contacting the fluid. Proceed with steps 1.4.-1.11.
      NOTE: Depending on the in vivo setup, it may be necessary to cut a length of platinum wire longer than 25 cm.
  2. Before connecting the CI probe to the headstage, ensure the entire electrical setup is properly grounded. Failure to do so may introduce unwanted electrical interference during the experimental recordings.
  3. Anesthetize the animals following a previously published report10.
  4. Perform surgery to expose the region of interest.
    NOTE: A median sternotomy was performed in the present study to expose the heart. Please see Kluge et al.10 for details on animal surgery.
  5. Gently remove the functionalized tip from the PBS rinse (step 1.11.), forward the hydodermic needle to the barbed C.I. probe and gently implant it in the region of interest prior to plugging the gold connector pin into the headstage. Once implanted, withdraw the hypodermic needle, leaving the electrode in place.
    NOTE: For the present study, the probe was placed in the mid-lateral wall of the left ventricular myocardium10.
  6. After ensuring proper electrical setup, proceed with standard and experimental testing protocols (step 2.2. and step 2.4.).
  7. Upon completion of the experiments, euthanize the animal following institutionally approved techniques.
    NOTE: In the present study, the animals are euthanized under deep anesthesia via induction of ventricular fibrillation10.

Results

Electrode fabrication and characterization
A flexible capacitive immunoprobe (CI probes) was fabricated, and a representative image is depicted in Figure 1A. The electrode potential was set by a computer-controlled voltage clamp circuit (Figure 1B), and the electrode was immersed in a polydopamine solution made in PBS. Polydopamine was electrodeposited onto the conductive electrode tip13 for functionalization. The c...

Discussion

The present protocol describes the manufacture and testing of a capacitive immunoprobe (CI probe) capable of detecting and measuring biomarkers of interest in both in vitro and in vivo settings. Detection is achieved by trapping the biomarker at the electrode tip. The trapping event alters the capacitive junction between a platinum wire capacitive immunoprobe and the surrounding conductive fluid environment, measured as a change in charge current in response to a potential shift in the probe. A unique e...

Disclosures

The authors declare no conflicts of interest, financial or otherwise.

Acknowledgements

We thank Dr. Olu Ajijola (UCLA Cardiac Arrhythmia Center) for expert support for the in vivo experiments. This work was supported by NIH U01 EB025138 (JLA, CS).

Materials

NameCompanyCatalog NumberComments
AgCl disc electrodeWarner Instruments (Holliston, MA)64-1307
Anti-NPY monoclonal antibodyAbcam, (Cambridge, MA)ab112473
Custom multichannel amplifier/ 1 MΩ feedback resistor multichannel headstageNPI Electronic, (Tamm, Germany)NABased on NPI VA-10M multichannel amplifier
Dopamine HClSigma Aldrich (St. Louis, MO)H8502-10G
Gold-plated male connector pinAMP-TE Connectivity (Amplimite)6-66506-1
HEKA LIH 8+8 analog-to-digital/digital-to-analog deviceHEKA Elektronik, (Holliston, MA)NA
Igor Pro data acquisition software, v. 7.08WaveMetrics, (Lake Oswego, OR)Software driving command potential and data acquisition was custom written
Masterflex L/S Standard Digital peristaltic pumpCole Palmer, (Vernon Hills, IL)
PFA-coated platinum wireA-M Systems, (Sequim, WA)7730000.005” bare diameter, 0.008” coated diameter
Silicone elastomerWorld Precision Instruments (Sarasota, FL)SYLG184
Synthetic porcine NPY peptideBachem (Torrance, CA)4011654
Synthetic porcine NPY peptideBachem (Torrance, CA)4011654

References

  1. Chow, S. L., et al. Role of Biomarkers for the prevention, assessment, and management of heart failure: A scientific statement from the American Heart Association. Circulation. 135 (22), 1054-1091 (2017).
  2. Goldstein, D. S. Adrenal responses to stress. Cellular and Molecular Neurobiology. 30 (8), 1433-1440 (2010).
  3. Ullman, B., Hulting, J., Lundberg, J. M. Prognostic value of plasma neuropeptide-Y in coronary care unit patients with and without acute myocardial infarction. European Heart Journal. 15 (4), 454-461 (1994).
  4. Farrell, D. M., et al. Angiotensin II modulates catecholamine release into interstitial fluid of canine myocardium in vivo. American Journal of Physiology-Heart and Circulatory Physiology. 281 (2), 813-822 (2001).
  5. Ardell, J. L., Foreman, R. D., Armour, J. A., Shivkumar, K. Cardiac sympathectomy and spinal cord stimulation attenuate reflex-mediated norepinephrine release during ischemia preventing ventricular fibrillation. JCI Insight. 4 (23), 131648 (2019).
  6. Franco-Cereceda, A., Lundberg, J. M., Dahlof, C. Neuropeptide Y and sympathetic control of heart contractility and coronary vascular tone. Acta Physiologica Scandinavica. 124 (3), 361-369 (1985).
  7. Habecker, B. A., et al. Molecular and cellular neurocardiology: development, and cellular and molecular adaptations to heart disease. The Journal of Physiology. 594 (14), 3853-3875 (2016).
  8. Hoang, J. D., Salavatian, S., Yamaguchi, N., Swid, M. A., Vaseghi, M. Cardiac sympathetic activation circumvents high-dose beta blocker therapy in part through release of neuropeptide Y. JCI Insight. 5 (11), 135519 (2020).
  9. Rigel, D. F. Effects of neuropeptides on heart rate in dogs: comparison of VIP, PHI, NPY, CGRP, and NT. American Journal of Physiology. 255, 311-317 (1988).
  10. Kluge, N., et al. Rapid measurement of cardiac neuropeptide dynamics by capacitive immunoprobe in the porcine heart. American Journal of Physiology-Heart and Circulatory Physiology. 320 (1), 66-76 (2021).
  11. Berggren, C., Bjarnason, B., Johansson, G. Capacitive biosensors. Electroanalysis. 13 (3), 173-180 (2001).
  12. Prodromidis, M. I. Impedimetric immunosensors-A review. Electrochimica Acta. 55 (14), 4227-4233 (2010).
  13. Lee, H., Dellatore, S. M., Miller, W. M., Messersmith, P. B. Mussel-inspired surface chemistry for multifunctional coatings. Science. 318 (5849), 426-430 (2007).
  14. Leszczyszyn, D. J., et al. Secretion of catecholamines from individual adrenal medullary chromaffin cells. Journal of Neurochemistry. 56 (6), 1855-1863 (1991).
  15. Pihel, K., Schroeder, T. J., Wightman, R. M. Rapid and selective cyclic voltammetric measurements of epinephrine and norepinephrine as a method to measure secretion from single bovine adrenal medullary cells. Analytical Chemistry. 66 (24), 4532-4537 (1994).
  16. Jaffe, E. H., Marty, A., Schulte, A., Chow, R. H. Extrasynaptic vesicular transmitter release from the somata of substantia nigra neurons in rat midbrain slices. The Journal of Neuroscience. 18 (10), 3548-3553 (1998).
  17. Walsh, P. L., Petrovic, J., Wightman, R. M. Distinguishing splanchnic nerve and chromaffin cell stimulation in mouse adrenal slices with fast-scan cyclic voltammetry. American Journal of Physiology-Cell Physiology. 300 (1), 49-57 (2011).
  18. Wolfe, J. T., Wang, H., Perez-Reyes, E., Barrett, P. Q. Stimulation of recombinant Ca(v)3.2, T-type, Ca(2+) channel currents by CaMKIIgamma(C). The Journal of Physiology. 538, 343-355 (2002).
  19. Chan, S. A., et al. Fast in vivo detection of myocardial norepinephrine levels in the beating porcine heart. American Journal of Physiology-Heart and Circulatory Physiology. 318 (5), 1091-1099 (2020).
  20. Chow, R. H., von Rüden, L., Sakmann, B., Neher, E. . Single-Channel Recording, Second Edition. , 245-275 (1995).
  21. Ren, Y., et al. Facile, high efficiency immobilization of lipase enzyme on magnetic iron oxide nanoparticles via a biomimetic coating. BMC Biotechnology. 11, 63 (2011).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Time resolved MeasurementNeuropeptide DynamicsCapacitive ImmunoprobePorcine HeartPeptide Transmitter LevelsDopamine SolutionPoly dopamine DepositionAntibody SolutionPBSElectro deposition ProtocolMicrotube PreparationInteractive Data Acquisition Software

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved